magic mushrooms; psilocybin therapy; depression

COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression The largest randomized, controlled, double-blind psilocybin therapy study ever completed shows rapid and sustained response...